A groundbreaking study led by an international team from the Universities of Geneva (UNIGE) and Marburg has unveiled a promising approach to cancer therapy. Researchers discovered that a mirror form of cysteine, an amino acid rich in sulfur, can significantly impede the growth of specific tumors while sparing healthy cells. This compound primarily targets certain cancer cells, disrupting vital biological processes such as cellular respiration and DNA synthesis. In experiments with mice, this treatment notably slowed the advancement of aggressive breast tumors. The findings are detailed in the journal Nature Metabolism.
Exploring Mirror-Image Amino Acids
Amino acids, the fundamental components of proteins, are akin to beads strung together to form essential biological structures. There are 20 amino acids that constitute the proteins found across all life forms. These amino acids exist in two forms: L (levorotatory) and D (dextrorotatory), which are mirror images of each other. While human biology predominantly utilizes the L forms for protein synthesis, the D forms are seldom employed.
D-Cysteine's Impact on Cancer Cells
The research, spearheaded by Jean-Claude Martinou, Honorary Professor at UNIGE's Faculty of Science, investigated how different amino acids affect cancer cell proliferation. Their experiments revealed that D-Cysteine (D-Cys), which contains a sulfur atom, effectively suppresses the growth of specific cancer cells in lab settings, without harming healthy cells.
Joséphine Zangari, a PhD student in Martinou's lab and the study's first author, noted, "The distinction between cancer and healthy cells is clear: D-Cys enters cells through a transporter found only on certain cancer cells. We observed that if this transporter is present on healthy cells, those cells cease to proliferate in the presence of D-Cys."
Mechanism of Action Against Cancer Cell Metabolism
Collaborating with Professor Roland Lill at the University of Marburg, the team identified how D-Cys disrupts cancer cell functions. It inhibits an essential enzyme called NFS1, located in mitochondria--the cell's energy centers. NFS1 is crucial for producing iron-sulfur clusters, which are vital for numerous cellular processes, including respiration and genetic integrity.
By blocking NFS1, D-Cys leads to diminished respiration, increased DNA damage, and halted cell cycles, collectively preventing cancer cells from growing and dividing.
Promising Results in Animal Trials
To evaluate the efficacy of this approach in live subjects, the researchers treated mice with aggressive mammary tumors that are typically challenging to manage. The results were encouraging, showing a marked slowdown in tumor growth with minimal side effects.
"This is a significant indication--we can potentially harness this specificity to target particular cancer cells," stated Jean-Claude Martinou. "However, further research is necessary to ascertain the safety and effective dosage of D-Cys for human use."
If subsequent studies validate its safety and effectiveness, D-Cysteine could pave the way for a straightforward and selective cancer treatment, particularly for tumors that express high levels of the transporter that facilitates D-Cys entry. This innovative strategy may also play a role in preventing metastasis, a critical phase in cancer progression.